Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBT (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed EBT for 16 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • Quarterly EBT rose 307.31% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.1 million through Dec 2025, up 105.21% year-over-year, with the annual reading at $6.0 million for FY2025, 102.16% up from the prior year.
  • EBT hit $4.6 million in Q4 2025 for Mesa Laboratories, up from $2.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $7.0 million in Q2 2025 to a low of -$275.3 million in Q1 2024.
  • Historically, EBT has averaged -$12.4 million across 5 years, with a median of $1.7 million in 2021.
  • Biggest five-year swings in EBT: soared 1981.54% in 2021 and later crashed 99297.83% in 2024.
  • Year by year, EBT stood at -$2.3 million in 2021, then soared by 181.85% to $1.9 million in 2022, then rose by 1.57% to $1.9 million in 2023, then tumbled by 213.93% to -$2.2 million in 2024, then surged by 307.31% to $4.6 million in 2025.
  • Business Quant data shows EBT for MLAB at $4.6 million in Q4 2025, $2.0 million in Q3 2025, and $7.0 million in Q2 2025.